Zobrazeno 1 - 9
of 9
pro vyhledávání: '"R. L. Kaiser"'
Autor:
A Z Dotti, E G Vilela, J M F Chebli, L A Chebli, D O Magro, F Steinwurz, M Argollo, N S Carvalho, J M L Parente, R S Parra, R L Perin, C Flores, E M Morsoletto, S D C Ferreira, J C Ludvig, R L Kaiser Jr, N S F Queiroz, M A G Faria, G M Nicollelli, A R Andrade, P G Kotze
Publikováno v:
Journal of Crohn's and Colitis. 17:i714-i715
Background Vedolizumab, a human monoclonal antibody that blocks integrin α4-β7, was approved for the management of Inflammatory Bowel Diseases. In real-world experience the number of patients using vedolizumab as first-line biological therapy was l
Autor:
R Froes, A R Andrade, M A G Faria, R S Parra, C Zaltman, H S P Souza, C H M D S Santos, M Bafutto, A B Quaresma, G O Santana, R L Rafael Luís Luporini, S F D Lima Junior, S J Miszputen, M M D Souza, G S P Herrerias, R L Kaiser Junior, C R D Nascimento, O Féres, J R D Barros, C D S Guimarães, L Y Sassaki, R Saad-Hossne
Publikováno v:
Journal of Crohn's and Colitis. 17:i963-i963
Background Brazil has shown an increase in Inflammatory Bowel Disease (IBD) cases. GEDIIB (Brazilian Organization of Crohn's Disease and Colitis) established a data platform to create a national registry of IBD patients. The study aimed to characteri
Autor:
Goodwin Watson, Robert Dunning Tilroe, Gifford G. Hale, Ronald J. Warnet, F. Eugene Wilhelm, James V. McDowell, R. L. Kaiser, David White, Lucien A. Buck, John A. Seiler, John Caffrey, Thomas E. Hulbert, David G. Robinson, John R. Watt, William A. Sutton
Publikováno v:
Change: The Magazine of Higher Learning. 2:56-59
Autor:
R L Kaiser
Publikováno v:
American Journal of Public Health and the Nations Health. 56:90-93
Publikováno v:
The American journal of tropical medicine and hygiene. 16(3)
Publikováno v:
American journal of epidemiology. 87(1)
Publikováno v:
American journal of hygiene. 76
Autor:
R L, KAISER, L D, WILLIAMS
Publikováno v:
Pennsylvania medical journal (1928). 65
Publikováno v:
Nursing Research. 12:257